Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

TxDOT Opts Balfour Beatty JV Team As Bidder For Dallas Horseshoe Project

Balfour Beatty Plc (BBY.L) said it has been named as best value bidder, as part of a design-build joint venture with Fluor Corp., to undertake the upgrades and replacements of river crossings in Dallas, Texas. The Texas Department of Transportation's, or TxDOT, estimate for the design, construction, utilities and right of way for the project is around $798 million, or 502 million pounds.

The 'Dallas Horseshoe' project calls for the upgrade and replacement of the I-30 and I-35E bridges and construction of additional lanes as well as the previously designed Margaret McDermott bridges. TxDOT will utilise design-build project delivery to shorten the construction schedule and lower the overall cost. The design work will start in early 2013 and construction will be completed in 2017.

Click here to receive FREE breaking news email alerts for Balfour Beatty Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.